Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.400
-0.200 (-4.35%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
$47,268
Profits / Employee
-$1,030,125
Market Cap
167.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OBIO News
- 5 weeks ago - Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board - GlobeNewsWire
- 6 weeks ago - Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference - GlobeNewsWire
- 7 weeks ago - Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors - GlobeNewsWire
- 4 months ago - Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 8 months ago - Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 11 months ago - Orchestra BioMed to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire